# Prospective Monitoring of Non-Vitamin K Oral Anticoagulants in Older Adults With Atrial Fibrillation and Frailty

> **NCT04878497** · — · UNKNOWN · sponsor: **Brigham and Women's Hospital** · enrollment: 1000000 (estimated)

## Conditions studied

- Atrial Fibrillation
- Frailty
- Anticoagulant-induced Bleeding
- Stroke

## Interventions

- **DRUG:** Warfarin
- **DRUG:** Dabigatran
- **DRUG:** Rivaroxaban
- **DRUG:** Apixaban
- **DRUG:** Edoxaban

## Key facts

- **NCT ID:** NCT04878497
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-30
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 1000000 (ESTIMATED)
- **Last updated:** 2021-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04878497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04878497, "Prospective Monitoring of Non-Vitamin K Oral Anticoagulants in Older Adults With Atrial Fibrillation and Frailty". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04878497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*